| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.948 | 89.444 | 115.391 | 101.663 | 83.780 | 51.940 | 61.810 | 60.894 | 56.687 | 43.423 |
| Total Income - EUR | 37.948 | 89.444 | 115.391 | 101.663 | 83.780 | 51.940 | 61.810 | 60.894 | 56.690 | 45.931 |
| Total Expenses - EUR | 5.085 | 5.116 | 5.301 | 5.624 | 5.919 | 9.515 | 10.332 | 10.885 | 12.916 | 13.978 |
| Gross Profit/Loss - EUR | 32.864 | 84.329 | 110.090 | 96.039 | 77.861 | 42.425 | 51.478 | 50.010 | 43.774 | 31.953 |
| Net Profit/Loss - EUR | 31.725 | 81.645 | 106.628 | 92.994 | 75.803 | 41.947 | 50.934 | 49.413 | 43.246 | 30.782 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermoclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.415 | 1.691 | 976 | 284 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 39.785 | 80.517 | 106.506 | 93.539 | 76.547 | 43.994 | 92.552 | 50.067 | 44.350 | 75.189 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 238 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 39.785 | 80.517 | 106.506 | 93.301 | 76.547 | 43.994 | 92.552 | 50.067 | 44.350 | 75.189 |
| Shareholders Funds | 41.841 | 81.708 | 106.690 | 93.055 | 75.863 | 42.006 | 92.008 | 49.470 | 43.304 | 73.844 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 359 | 501 | 793 | 767 | 684 | 1.988 | 544 | 597 | 1.046 | 1.345 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermoclinic S.r.l.